SCHEMBL3933150

SCHEMBL3933150

O=C(Nc1cccnc1)C1CN(C(=O)O)CCN1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 2/20 0.46
ITGB3 P05106 2/20 0.45
ITGA2B P08514 2/20 0.45
PKM P14618 2/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
HPGD P15428 1/20 0.43
CYP2C19 P33261 1/20 0.43
NAMPT P43490 1/20 0.43
ALDH1A1 P00352 2/20 0.42
DPP4 P27487 1/20 0.42
ITGAV P06756 1/20 0.42
EPHX2 P34913 1/20 0.42
KDM4E B2RXH2 1/20 0.41
KMT2A Q03164 1/20 0.41
LMNA P02545 1/20 0.41
HIF1A Q16665 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL782771 0.85 GPR119 (0.50) ITGB3ITGA2BNAMPTKMT2A
SCHEMBL3935992 0.78 GRIN2B (0.47) GRIN2BITGB3ITGA2BPKMNPC1
SCHEMBL29129911 0.77 ITGB3 (0.59) ITGB3ITGA2BPKMNPC1RAB9A
SCHEMBL28570403 0.77 ITGB3 (0.59) ITGB3ITGA2BPKMNPC1RAB9A
SCHEMBL4977339 0.77 NPC1 (0.47) PKMNPC1RAB9AKDM4EKMT2A
SCHEMBL28989369 0.75 CHRNB2 (0.50) GRIN2BCYP1A2CYP2C9CYP2C19ALDH1A1
SCHEMBL10650116 0.74 CYP1A2 (0.47) PKMNPC1RAB9ACYP1A2CYP2C9
SCHEMBL4612556 0.73 USP2 (0.47) NPC1RAB9AHPGDNAMPTALDH1A1
SCHEMBL15021499 0.73 ULK1 (0.48)
SCHEMBL3768246 0.72 TRPV1 (0.60) GRIN2BPKMNPC1RAB9ANAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044038-A2 NOVEL PIPERAZINES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF Cornerstone Therapeutics Inc. (US) 2009-04-08 EP disclosed
WO-2007146066-A2 NOVEL PIPERAZINES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF CRITICAL THERAPEUTICS, INC. (US) 2007-12-21 WO disclosed